SCHEMBL7411650

SCHEMBL7411650

COc1cc(OC(C)=O)c(C(=O)Cc2ccccc2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TNFSF11 O14788 1/20 0.47
HIF1A Q16665 1/20 0.47
POLB P06746 1/20 0.47
TSHR P16473 2/20 0.47
PTGS1 P23219 2/20 0.45
PTGS2 P35354 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
ESR1 P03372 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
HMGB1 P09429 1/20 0.44
HPGD P15428 1/20 0.44
GGT1 P19440 1/20 0.44
BLM P54132 1/20 0.44
NAPRT Q6XQN6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10958946 0.81 GAA (0.52) USP2TP53GAANPSR1HIF1A
SCHEMBL6611954 0.79 MAPT (0.63) NPSR1TNFSF11TSHRPTGS1PTGS2
SCHEMBL3282912 0.77 NPC1 (0.63) USP2TP53GAAPOLBALDH1A1
SCHEMBL29861033 0.77 NPC1 (0.63) USP2TP53GAAPOLBALDH1A1
SCHEMBL17637149 0.77 HSD11B1 (0.63) USP2TP53NPSR1TSHRKDM4E
SCHEMBL12950516 0.77 HSP90AA1 (0.55) USP2TP53GAANPSR1HIF1A
SCHEMBL8318992 0.77 ALDH1A1 (0.49) USP2TP53GAANPSR1HIF1A
SCHEMBL15680262 0.76 LCK (0.61) USP2TNFSF11TSHRPTGS1PTGS2
SCHEMBL4248920 0.76 HIF1A (0.46) USP2TP53GAANPSR1HIF1A
Phenylacetic Acid SCHEMBL28250164 0.76 AKR1B1 (0.55) GAAPOLBTSHRPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002088096-A1 COMPOUNDS INHIBITING CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, PREPARATION AND USES THEREOF NEURO3D (FR) 2002-11-07 WO disclosed